Jump to content

login

Open Platform - 1 June 2008

One hub to rule them all

The rapid rise in the use of STP for OTC derivatives trade affirmations and confirmations has triggered the establishment of a number of players over recent years with platforms from DTCC and SwapsWire dominating the market. However, the fact that no single provider has emerged as the prevailing platform has presented challenges for hedge funds. By Digiterre’s Ravi Sawhney

Hedge funds are not alone in this operational challenge – traditional asset managers are also affected due to the increased use of OTC derivatives in their retail funds facilitated by the loosening of investment regulations ushered in by the UCITS III directive. Several platforms are owned or sponsored by the sell side and their requirements, and as a result it is fair to say that, to date, the majority of the benefits are being realised by the sell-side institutions and not the ...

 

To read this story please register or login

Full access to www.buysidetechnology.com is only available to subscribers to Buy-Side Technology and people who have signed up for a 4 week online trial.

Individual subscribers, corporate subscribers and trialists now need to enter their usernames and passwords to get access to the Buy-Side Technology site.

Please enter your username and password below

USERNAME :
PASSWORD :
Remember me :
What to do if you do not know your username and password:

If you are a Buy-Side Technology subscriber or trialist, click here and we will e-mail you straight away with your username and password.

What to do if you are not a Buy-Side Technology subscriber or trialist:

1. If you are not a Buy-side Technology subscriber or trialist, click here to get a FREE 4 week online trial of www.buysidetechnology.com.

2. If you have already had a trial to www.buysidetechnology.com, please click here to activate your subscription now.